Biosimilars as a Future, Promising Solution for Financial Toxicity: A Review with Emphasis on Bevacizumab

A biosimilar is a biochemical product like another already approved biologic agent, known as the reference agent. To be endorsed by the Food and Drug Administration (FDA), biosimilars must demonstrate that they are as safe and effective as their reference item, with no clinical distinction. Humanize...

Full description

Saved in:
Bibliographic Details
Published in:Cureus
Main Authors: Saleem, Tabinda, Qurashi, Hafiz, Jamali, Munira, Chan Gomez, Janet, Kanderi, Tejaswi
Format: Artigo
Language:Inglês
Published: Cureus 2020
Subjects:
Internal Medicine
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7437115/
https://ncbi.nlm.nih.gov/pubmed/32832297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.9300
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items